Cristina Plaza Alonso

Cristina Plaza Alonso

Auto-generated profile, based on publicly available information

Cristina Plaza Alonso

INDIVO Group, Aragon Government Research Group B30_23R, Zaragoza, Spain

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in Minerva Urology and Nephrology
Verified
Journal Article
Closed access
Riccardo LombardoRiccardo Lombardo
Riccardo Lombardo
AAAnton Zarraonandia Andraca
Anton Zarraonandia Andraca
GTGiorgia Tema
Giorgia Tema
FCFabiana Cancrini
Fabiana Cancrini
AVAlmudena Carrion Valencia
Almudena Carrion Valencia
MMManuel Ruibal Moldes
Manuel Ruibal Moldes
Article: How many procedures are needed to achieve learning curve of Millin simple laparoscopic prostatectomy? - Minerva Urology and Nephrology 2022 April;74(2):225-32 - Minerva Medica - Journals

31 March 2025 in Journal of Urologic Oncology
Verified
Journal Article
Open access
PDF file
MPMónica Sanz del Pozo
Mónica Sanz del Pozo
CACristina Plaza Alonso
Cristina Plaza Alonso
ÁGÁlvaro Linacero Gracia
Álvaro Linacero Gracia
ÁDÁngela Pradilla Dieste
Ángela Pradilla Dieste
JHJavier Bascuas Hernández
Javier Bascuas Hernández
BGBerta Sáez Gutiérrez
Berta Sáez Gutiérrez
Purpose: The present study aimed at determining the expression of carbonic anhydrase IX (CAIX) in tissue and serum of patients with clear cell renal cell carcinoma (ccRCC) and its relationship with clinical-pathological parameters; assessing CAIX as a marker of progression and survival; and studying the relationship of CAIX concentration in serum before and after surgical intervention.Materials and Methods: Immunohistochemistry was used to assess the expression of CAIX in tumor and adjacent healthy renal tissues. The concentration of CAIX in serum was determined using commercial enzyme-linked immunosorbent assay before and 24 hours after radical nephrectomy in 60 patients diagnosed with ccRCC. SPSS ver. 28.0.1.0 was used for descriptive and inferential statistical analysis and graphics. A significance level of 0.05 was considered for all statistical tests performed.Results: CAIX expression was positive in 59 of the 60 samples of tumor renal tissue, and negative in the 60 samples of healthy renal tissues. Median serum CAIX concentration was higher before nephrectomy (178.25 pg/mL) than after it (59.30 pg/mL), with a high correlation between pre-and postsurgical measurements (r=0.891). Significant differences were found in CAIX concentration according to the following variables: TNM, tumor stage, Fuhrman nuclear grade, progression, and death. Serum CAIX concentration before nephrectomy correlated with disease progression and overall survival, with a hazard ratio of 4.849 for CAIX values greater than 169.95 pg/mL.Conclusion: CAIX expression in tumor renal tissue was specific, but not clinically useful as a prognostic marker. Measurements of CAIX in serum obtained pre- and postsurgical interventions showed good prognostic potential, correlating with clinical-pathological parameters and estimating the risk of progression. Presurgical intervention serum CAIX concentrations higher than 169.95 pg/mL indicated an almost 5-fold increased risk of death.

1 July 2020 in European Urology Open Science
Verified
Journal Article
Open access
GTG. Tema
G. Tema
RLR. Lombardo
R. Lombardo
ASA. Sica
A. Sica
AAA. Zarraonandia Andraca
A. Zarraonandia Andraca
CAC. Plaza Alonso
C. Plaza Alonso
RGR. Giulianelli
R. Giulianelli

1 July 2020 in European Urology Open Science
Verified
Journal Article
Open access
FCF. Cancrini
F. Cancrini
AAA. Zarraonandia Andraca
A. Zarraonandia Andraca
OVO.A. Voglino
O.A. Voglino
RLR. Lombardo
R. Lombardo
AVA. Carrion Valencia
A. Carrion Valencia
MMM. Ruibal Moldes
M. Ruibal Moldes